Home
About
Publications Trends
Recent Publications
Expert Search
Archive
inflammatory bowel diseases
What Types of Cancer are Common in IBD Patients?
The most common cancer associated with IBD is
colorectal cancer
. However, patients with Crohn's disease may also have an increased risk of small bowel cancer, and in rare cases, there can be an association with
lymphoma
and
skin cancer
.
Frequently asked queries:
What are Inflammatory Bowel Diseases (IBD)?
How is IBD Related to Cancer?
What Types of Cancer are Common in IBD Patients?
What are the Risk Factors for Cancer in IBD Patients?
How Can IBD-Associated Cancer be Prevented?
What are the Treatment Options for IBD-Associated Cancer?
How Important is Ongoing Monitoring and Follow-Up?
What is Computational Complexity in Cancer Research?
How Does GVHD Occur?
How is Glycopyrrolate Administered?
How Does p53 Work?
What Types of Blood Tests are Commonly Used in Cancer Detection?
How Do Sagittarius and Cancer Interact?
Why is Intraoperative Imaging Important in Cancer Surgery?
What Are the Key Issues in Cancer Advocacy?
What are Face Shields?
Why Are Cancer Patients at Higher Risk for Fungal Infections?
Why Are Cancer Patients More Susceptible?
Is Gastric Bypass Covered by Insurance?
How is CD47 Targeted in Cancer Therapy?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe